120 related articles for article (PubMed ID: 10083066)
1. Administration of exogenous interleukin-2 enhances obliterative airway disease in cyclosporine-treated rats following tracheal allografts.
Takao M; Gu Y; Shimamoto A; Adachi K; Namikawa S; Yada I
Transplant Proc; 1999; 31(1-2):180-1. PubMed ID: 10083066
[No Abstract] [Full Text] [Related]
2. Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease.
Yonan NA; Bishop P; el-Gamel A; Hutchinson IV
Transplant Proc; 1998 Aug; 30(5):2207-9. PubMed ID: 9723443
[No Abstract] [Full Text] [Related]
3. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
[TBL] [Abstract][Full Text] [Related]
4. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans.
Boehler A; Chamberlain D; Kesten S; Slutsky AS; Liu M; Keshavjee S
Transplantation; 1997 Jul; 64(2):311-7. PubMed ID: 9256193
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans.
Remund K; Rechsteiner T; Rentsch K; Vogt P; Russi EW; Boehler A
Transplantation; 2008 Mar; 85(5):726-31. PubMed ID: 18337667
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853
[No Abstract] [Full Text] [Related]
10. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats.
Ikonen TS; Brazelton TR; Berry GJ; Shorthouse RS; Morris RE
Transplantation; 2000 Sep; 70(6):857-63. PubMed ID: 11014638
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease.
Lemaître PH; Vokaer B; Charbonnier LM; Iwakura Y; Field KA; Estenne M; Goldman M; Leo O; Remmelink M; Le Moine A
Am J Transplant; 2013 Mar; 13(3):611-20. PubMed ID: 23331973
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts.
Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB
J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation.
Koskinen P; Kallio E; Tikkanen J; Bruggeman C; Häyry P; Lemström K
Transplant Proc; 1997; 29(1-2):798. PubMed ID: 9123530
[No Abstract] [Full Text] [Related]
14. No gender difference in development of obliterative airway disease in rat tracheal allografts.
Antus B; Fillinger J; Sebe A; Jeney C; Soltesz I; Horvath I
Exp Mol Pathol; 2006 Dec; 81(3):235-8. PubMed ID: 16859678
[TBL] [Abstract][Full Text] [Related]
15. Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease.
Jordan JL; Hurley CL; Lee TD; Hirsch GM
J Heart Lung Transplant; 2003 Mar; 22(3):357-60. PubMed ID: 12633704
[TBL] [Abstract][Full Text] [Related]
16. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts.
Roth-Eichhorn S; Schade I; Kasper M; Ploetze K; Wunderlich J; Funk RH; Schueler S
J Heart Lung Transplant; 2001 Nov; 20(11):1188-98. PubMed ID: 11704479
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.
Fillinger J; Antus B
Exp Lung Res; 2010 Dec; 36(10):625-31. PubMed ID: 20860540
[TBL] [Abstract][Full Text] [Related]
19. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas.
Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J
J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618
[TBL] [Abstract][Full Text] [Related]
20. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts.
Koskinen PK; Kallio EA; Krebs R; Lemström KB
Am J Respir Crit Care Med; 1997 Jan; 155(1):303-12. PubMed ID: 9001329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
